Navigation Links
Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium
Date:12/9/2010

BRIDGEWATER, N.J., Dec. 9, 2010 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the final survival analysis (10-year follow-up) of the BCIRG001 study that included a Taxotere® (docetaxel) Injection Concentrate chemotherapy treatment regimen in the adjuvant breast cancer setting, as well as data from iniparib (BSI-201) pre-clinical and clinical breast cancer studies will be featured during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas from December 8 to 12, 2010.  

During SABCS, the final (10-year follow up) survival analysis of the BCIRG001 study that included sanofi-aventis' chemotherapy drug Taxotere, in combination with doxorubicin and cyclophosphamide, in women with operable node-positive breast cancer will be presented. Also being presented are data from pre-clinical and clinical studies involving the sanofi-aventis investigational compound iniparib (BSI-201), which is being studied in breast cancer.  Iniparib is a novel investigational small molecule with poly (ADP-ribose) polymerase (PARP) inhibitory activity.

Key events at SABCS include: Taxotere Data:Abstract #S4-3

Friday, Dec. 10

3:45 PM CSTAn oral presentation featuring final results from the ten-year follow-up analysis of the BCIRG 001 trial Iniparib Data:Abstract #P5-06-09

Phase 1b/2 MBC trial

Saturday, Dec. 11

5:30 - 7:30 PM CSTData from a Phase 1b study to assess the safety and tolerability of the investigational compound iniparib (BSI-201) in combination with irinotecan in patients with metastatic breast cancer (MBC)Iniparib Data:Abstract # P6-04-12

Activity in TNBC Cell lines

Sunday, Dec. 12

7:00 - 8:30 AM CSTData from a preclinical study assessing the cell cycle effects of the investigational compound iniparib (BSI-201) in combination
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
2. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
3. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
4. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
5. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
6. Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
7. European Hospital Anticoagulant Market Dominated by Sanofi-Aventiss Clexane
8. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
9. Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
10. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
11. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 /PRNewswire/ -- Mindray Medical International ... manufacturer and marketer of medical devices worldwide, today announced ... first quarter ended Mar 31, 2015 after the U.S. ... hold an earnings conference call at 8:00 AM on ... May 12, 2015 Beijing/Hong Kong Time). ...
(Date:4/21/2015)... , April 21, 2015  Legal-Bay LLC, The ... maker, Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval ... PE. According to PBR, Boehringer submitted a supplemental ... hopes that Pradaxa will be approved for the ... embolism (PE) for patients who have undergone a ...
(Date:4/20/2015)... PORTLAND, Ore. , April 20, 2015 /PRNewswire/ ... the National Academy of Sciences (PNAS) demonstrates ... & Science University,s Casey Eye Institute ... causes of blindness. Optical coherence tomography (OCT) angiography ... management of these diseases. OHSU researchers ...
Breaking Medicine Technology:Mindray to Report 2015 First Quarter Financial Results on May 11, 2015 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 3Study shows new technology may improve management of leading causes of blindness 2Study shows new technology may improve management of leading causes of blindness 3Study shows new technology may improve management of leading causes of blindness 4Study shows new technology may improve management of leading causes of blindness 5
... Nov. 1, 2010 According to the American Diabetes ... States in 2007 were estimated at $174 billion.  Millions ... and many more are unaware that they are at ... with type II diabetes use pills to manage their ...
... HRC ) today announced the appointment of ... Officer. Guinan is currently Chief Procurement Officer for Johnson ... 13, 2010.   During his career ... senior financial positions, including Vice President- Finance, Global Pharmaceutical ...
Cached Medicine Technology:Stater Bros. Super Rx Pharmacy Offers FREE Diabetic Medications 2Hill-Rom Appoints Mark Guinan as Chief Financial Officer 2
(Date:4/21/2015)... 21, 2015 According to a recent ... 7th Gov. Wolf has made naloxone available for anyone ... naloxone from a pharmacy without a doctor’s order- in ... with drug addiction. Pennsylvania’s state police will also begin ... ingredient in Narcan) is an opiate overdose reversal medication. ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Dr. Aaron Choroomi, ... 101 Dental Group are now offering a valuable discount on ... included in the promotional price of only $1695 for a ... available to patients for a limited time. , "There ... simply based on the price," dental implants dentist , ...
(Date:4/21/2015)... 2015 What do Bill Gates, Hillary Clinton, ... Ted Turner have in common? They are all on NowItCounts ... Americans 50+. In a 16-page spread and cover story, Richard ... magazines and 25 websites, along with his dedicated team, chose ... through the unique lens of its audience. , To come ...
(Date:4/21/2015)... April 21, 2015 Zane Benefits, a ... today its CEO Rick Lindquist has been selected as ... , According to Rick Lindquist, “There is a massive ... Zane Benefits’ small business solutions are at its forefront. ... by Employee Benefit Adviser’s Rising Stars.” , According to ...
(Date:4/21/2015)... April 21, 2015 Let's face it; a ... through fancy products and complex routines for hundreds of dollars. ... through suncare, not gimmicks, as the sun is the leading ... good suncare is more than just daily sun protection; it ... Block Island Organics’ new Purifying Facial Cleanser and ...
Breaking Medicine News(10 mins):Health News:Drug Rehab Philadelphia Comments on Gov. Wolf’s Decision to Make Naloxone Widely Available 2Health News:101 Dental Group is Now Offering a Promotion on Dental Implants 2Health News:NiC 50: 2015 Ranking of the Most Powerful Americans 50+ 2Health News:NiC 50: 2015 Ranking of the Most Powerful Americans 50+ 3Health News:NiC 50: 2015 Ranking of the Most Powerful Americans 50+ 4Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2Health News:Block Island Organics Debunks Skin Care Myths with New Products 2Health News:Block Island Organics Debunks Skin Care Myths with New Products 3
... that are commonly referred to as non-communicable diseases could cause ... of the health care cost by 2015, according to estimates ... million people in 2005 to NCD, the toll might reach ... Robert Beaglehole, director of NCD, WHO. ,He was ...
... Pradesh, 136 have been found to be due to ... announced this shocking report in the Assembly. ... identify individuals/health organizations involved in the controversial blood transfusion ... would be implemented to avoid such instances in the ...
... Birth under the Guangdong Family Planning Research Institute in ... discovered 39 cases of new abnormal chromosomes. // ... scientists for genetic and cloning researches. ,Director ... these cases of abnormal chromosomes have been verified by ...
... AIDS/HIV, which is haunting the world for over two decades ... countries in the Asia Pacific // Region would meet in ... treatment and prevention would be the main focus of the ... target to expand AIDS treatment to over 3 million universal ...
... the second leading cause of blindness, worldwide would affect 60 ... end of 2020, // based on a projection in the ... and Africa would be the worst affected by the disabling ... of all glaucoma cases by then. Six out of ...
... treat pneumonia, bronchitis and other infections. Bristol-Myers Squibb Co. ... U.S. Food and Drug Administration said that the drug ... from blood-sugar changes due to this drug. ... of serious cases of hypoglycemia (low blood sugar) and ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: